EPM’s Medicine Revolution
Novel therapeutics from synthetic cannabinoid acids for a healthier and brighter future
EPM is developing prescription medicine based on novel discoveries of synthetic cannabinoid acids to address unmet patient needs. These innovations represent new treatment options and aim at alleviating a wide range of therapeutic conditions for millions of patients worldwide.
EPM is developing cannabinoid acid-based therapeutic solutions providing alternative treatments for patients. This is the driving force behind EPM’s research program, which is based on 14 IP protected APIs. Currently EPM’s focus is on two main therapeutic conditions: Metabolic and skin disorders.
